Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment
Clinical trial NCT07285941 · RECRUITING
Trial details
- NCT number
- NCT07285941
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-04
- Primary completion
- 2027-01-04
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.